Literature DB >> 8604560

Stages of Marek's disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression.

L M Volpini1, B W Calnek, M J Sekellick, P I Marcus.   

Abstract

Cytokines in conditioned medium can suppress expression of viral internal antigens (VIA) in lymphocytes latently infected with Marek's disease virus. In the present study, conditioned media produced by spleen cells stimulated with concanavalin A or by mixed-lymphocyte reaction had significantly greater (P < 0.05) VIA-suppressive activity with lymphocytes harvested from birds at 14 days post infection than with those collected at 7 days. This finding defines two stages during the latent period in which sensitivity of lymphocytes to cytokine modulation of viral expression differs. Suppression involved proteins representing immediate-early, early and late viral antigens. Physico-chemical characterization of the suppressive factor in conditioned medium was consistent with that expected of interferon. Indeed, natural interferon prepared from avian reovirus-exposed chicken embryo cells, and recombinant chicken interferon, both mimicked the activity of conditioned medium and were more suppressive with lymphocytes from the later stage of latency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8604560     DOI: 10.1016/0378-1135(95)00056-g

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease.

Authors:  Pete Kaiser; Greg Underwood; Fred Davison
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures.

Authors:  Z Xing; K A Schat
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken.

Authors:  H C Liu; H J Kung; J E Fulton; R W Morgan; H H Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus.

Authors:  Z Xing; K A Schat
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Transcriptional profiling of Marek's disease virus genes during cytolytic and latent infection.

Authors:  Mohammad Heidari; Marianne Huebner; Dmitry Kireev; Robert F Silva
Journal:  Virus Genes       Date:  2008-02-12       Impact factor: 2.332

7.  Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells.

Authors:  William N Mwangi; Lorraine P Smith; Susan J Baigent; Richard K Beal; Venugopal Nair; Adrian L Smith
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

8.  Toll-like receptor 3 pathway restricts Marek's disease virus infection.

Authors:  Haitao Zou; Ruixue Su; Jing Ruan; Hongxia Shao; Kun Qian; Jianqiang Ye; Aijian Qin
Journal:  Oncotarget       Date:  2017-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.